Muscular Dystrophy, Duchenne
"Muscular Dystrophy, Duchenne" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
Descriptor ID |
D020388
|
MeSH Number(s) |
C05.651.534.500.300 C10.668.491.175.500.300 C16.320.322.562 C16.320.577.300
|
Concept/Terms |
Muscular Dystrophy, Duchenne- Muscular Dystrophy, Duchenne
- Childhood Pseudohypertrophic Muscular Dystrophy
- Duchenne Muscular Dystrophy
- Dystrophy, Duchenne Muscular
- Duchenne-Type Progressive Muscular Dystrophy
- Duchenne Type Progressive Muscular Dystrophy
- Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type
- Muscular Dystrophy, Pseudohypertrophic
- Dystrophies, Pseudohypertrophic Muscular
- Dystrophy, Pseudohypertrophic Muscular
- Muscular Dystrophies, Pseudohypertrophic
- Pseudohypertrophic Muscular Dystrophies
- Pseudohypertrophic Muscular Dystrophy
- Muscular Dystrophy, Pseudohypertrophic, Childhood
- Progressive Muscular Dystrophy, Duchenne Type
- Pseudohypertrophic Childhood Muscular Dystrophy
- Pseudohypertrophic Muscular Dystrophy, Childhood
- Childhood Muscular Dystrophy, Pseudohypertrophic
- Muscular Dystrophy, Childhood, Pseudohypertrophic
|
Below are MeSH descriptors whose meaning is more general than "Muscular Dystrophy, Duchenne".
- Diseases [C]
- Musculoskeletal Diseases [C05]
- Muscular Diseases [C05.651]
- Muscular Disorders, Atrophic [C05.651.534]
- Muscular Dystrophies [C05.651.534.500]
- Muscular Dystrophy, Duchenne [C05.651.534.500.300]
- Nervous System Diseases [C10]
- Neuromuscular Diseases [C10.668]
- Muscular Diseases [C10.668.491]
- Muscular Disorders, Atrophic [C10.668.491.175]
- Muscular Dystrophies [C10.668.491.175.500]
- Muscular Dystrophy, Duchenne [C10.668.491.175.500.300]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Genetic Diseases, X-Linked [C16.320.322]
- Muscular Dystrophy, Duchenne [C16.320.322.562]
- Muscular Dystrophies [C16.320.577]
- Muscular Dystrophy, Duchenne [C16.320.577.300]
Below are MeSH descriptors whose meaning is more specific than "Muscular Dystrophy, Duchenne".
This graph shows the total number of publications written about "Muscular Dystrophy, Duchenne" by people in this website by year, and whether "Muscular Dystrophy, Duchenne" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 1 | 2 | 2003 | 1 | 0 | 1 | 2005 | 0 | 1 | 1 | 2006 | 1 | 1 | 2 | 2008 | 1 | 0 | 1 | 2009 | 1 | 0 | 1 | 2010 | 4 | 0 | 4 | 2011 | 1 | 1 | 2 | 2013 | 1 | 1 | 2 | 2014 | 0 | 1 | 1 | 2015 | 2 | 0 | 2 | 2016 | 1 | 0 | 1 | 2017 | 2 | 2 | 4 | 2018 | 1 | 0 | 1 | 2019 | 1 | 0 | 1 | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Muscular Dystrophy, Duchenne" by people in Profiles.
-
Demonbreun AR, Fallon KS, Oosterbaan CC, Vaught LA, Reiser NL, Bogdanovic E, Velez MP, Salamone IM, Page PGT, Hadhazy M, Quattrocelli M, Barefield DY, Wood LD, Gonzalez JP, Morris C, McNally EM. Anti-latent TGFß binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy. Sci Transl Med. 2021 Sep 08; 13(610):eabf0376.
-
Quattrocelli M, Zelikovich AS, Jiang Z, Peek CB, Demonbreun AR, Kuntz NL, Barish GD, Haldar SM, Bass J, McNally EM. Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming. JCI Insight. 2019 12 19; 4(24).
-
Gordish-Dressman H, Willmann R, Dalle Pazze L, Kreibich A, van Putten M, Heydemann A, Bogdanik L, Lutz C, Davies K, Demonbreun AR, Duan D, Elsey D, Fukada SI, Girgenrath M, Patrick Gonzalez J, Grounds MD, Nichols A, Partridge T, Passini M, Sanarica F, Schnell FJ, Wells DJ, Yokota T, Young CS, Zhong Z, Spurney C, Spencer M, De Luca A, Nagaraju K, Aartsma-Rus A. "Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic. J Neuromuscul Dis. 2018; 5(4):407-417.
-
McNally EM, Wyatt EJ. Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic. Circulation. 2017 09 12; 136(11):979-981.
-
Quattrocelli M, Salamone IM, Page PG, Warner JL, Demonbreun AR, McNally EM. Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb-Girdle Muscular Dystrophy. Am J Pathol. 2017 Nov; 187(11):2520-2535.
-
Quattrocelli M, Barefield DY, Warner JL, Vo AH, Hadhazy M, Earley JU, Demonbreun AR, McNally EM. Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy. J Clin Invest. 2017 Jun 01; 127(6):2418-2432.
-
Gutpell KM, Tasevski N, Wong B, Hrinivich WT, Su F, Hadway J, Desjardins L, Lee TY, Hoffman LM. ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice. PLoS One. 2017; 12(3):e0174315.
-
Smith LR, Hammers DW, Sweeney HL, Barton ER. Increased collagen cross-linking is a signature of dystrophin-deficient muscle. Muscle Nerve. 2016 06; 54(1):71-8.
-
Mehmood M, Hor KN, Al-Khalidi HR, Benson DW, Jefferies JL, Taylor MD, Egnaczyk GF, Raman SV, Basu SK, Cripe LH, Germann J, Mazur W. Comparison of right and left ventricular function and size in Duchenne muscular dystrophy. Eur J Radiol. 2015 Oct; 84(10):1938-42.
-
McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Groh WJ, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, Raman SV, Spurney CF, Targum SL, Wagner KR, Markham LW. Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy. Circulation. 2015 May 05; 131(18):1590-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|